Lung cancer is a major health concern, significantly contributing to cancer-related deaths across the population. Although often associated with smoking, this cancer can also develop due to environmental factors or genetic predisposition. Early detection and a comprehensive treatment approach are critical to improving outcomes for those affected.
Several factors contribute to the development of lung cancer, with smoking being the leading cause. However, environmental exposure can also be an issue to other environmental and genetic factors.
Tobacco use is responsible for about 85% of lung cancer cases. The risk increases with prolonged smoking, but even second-hand smoke can be harmful.
Harmful substances like asbestos, radon gas, and industrial chemicals can increase the risk, especially for those working in high-risk industries.
Long-term exposure to high levels of pollution, particularly in urban areas, may contribute to the onset of lung cancer.
Genetic factors can play a role in lung cancer, and having a family member with the disease may increase risk.
Individuals who have undergone radiation therapy for other cancers may face a higher risk of developing lung cancer later in life.
Some people may develop lung cancer due to spontaneous genetic mutations unrelated to smoking or other environmental causes.
In its early stages, lung cancer may not cause noticeable symptoms. As the disease progresses, common symptoms include:
Lung cancer is diagnosed through a combination of physical exams, imaging, and laboratory tests:
Lung cancer treatment is varialized based on the cancer type, stage, and the patient's overall health. The most common treatments include:
Lobectomy: Removing one lobe of the lung.
Pneumonectomy: Complete removal of a lung, typically for larger or more aggressive tumors.
Chemotherapy is used to kill or shrink cancer cells and is often combined with surgery or radiation therapy. It may also be used as the primary treatment for advanced stages.
Certain medications target specific genetic mutations within cancer cells (e.g., EGFR, ALK). Targeted therapy can be highly effective with fewer side effects compared to traditional chemotherapy.
Radiation therapy is a crucial treatment for lung cancer, particularly for patients unable to undergo surgery or for those whose tumors are inoperable. Newer techniques in radiation therapy allow for more precise treatment, sparing healthy tissues.
Proton therapy is an advanced form of radiation that precisely targets cancerous cells while minimizing damage to surrounding healthy tissues, such as the heart or esophagus. It allows for higher radiation doses, improving the chance of tumor control while reducing side effects.
CyberKnife is a robotic system that delivers highly targeted radiation to lung tumors with extreme precision. It tracks the tumor’s movement in real-time (important for lung cancer, where tumors move as a person breathes). CyberKnife requires fewer treatment sessions, offering patients a non-invasive, pain-free alternative to traditional surgery.
Immunotherapy uses drugs to help the body’s immune system recognize and fight cancer cells. It is often used in combination with other treatments and can be particularly effective for certain types of lung cancer.
For advanced lung cancer, palliative care focuses on relieving symptoms such as pain or breathing difficulties, aiming to improve the quality of life.
Healthcare International is a medical value travel undertaking that connects patients with world-class healthcare services across India and other medical destinations. It is a top-tier hospital network and over hundreds of expert clinicians to accord personalized care, advanced treatment, and global access to ensure the best possible medical outcomes for each of its patients.
Copyright © 2024, Healthcare International
